Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Maya Bucher"'
Autor:
François Kuonen, Maya Bucher, Laurence de Leval, Maxime Vernez, Michel Gilliet, Curdin Conrad, Laurence Feldmeyer
Publikováno v:
Case Reports in Dermatology, Vol 6, Iss 1, Pp 37-42 (2014)
Background: Hepatosplenic T cell lymphoma (HSTL) is a rare but very aggressive peripheral T cell lymphoma whose initial silent clinical presentation unfortunately delays the diagnosis and worsens the prognosis of patient survival. Efforts should be a
Externí odkaz:
https://doaj.org/article/40a7d2d9d31044c8bb37008c1a937f9f
Publikováno v:
Revue Médicale Suisse. 17:1295-1300
Publikováno v:
Revue medicale suisse. 17(745)
Athlete's skin is under great stress and its integrity is essential. Knowledge and prevention of sports-related dermatoses are fundamental to athlete's the management. Hereby we review common sport-related affections classified by their etiologies (t
Publikováno v:
Praxis. 107:153-157
Zusammenfassung. Für die Entfernung von Tätowierungen sind Q-Laser derzeit die beste Behandlung. Die richtige Wahl des Lasertyps, basierend auf der Farbe der Tätowierung und des Hauttyps, ist entscheidend, um gute Ergebnisse zu erzielen. In diesem
Autor:
Maya Bucher, Hasna Bouchaab, Olivier Michielin, Stefan Zimmerman, Krisztian Homicsko, Igor Letovanec, Olivier Gaide, Solange Peters
Publikováno v:
Melanoma Research. 24:496-500
BRAF inhibitory therapy is the mainstream treatment for BRAF mutant advanced melanoma. However vemurafenib, a type I mutant BRAF V600 inhibitor, induces an array of proliferative skin disorders from keratosis pilaris-like and keratoacanthoma-like les
Autor:
Ezziat Sakina, Leonidas Zografos, Gürkan Kaya, Rosanna Pescini Gobert, Alexandre Moulin, Donata Rimoldi, Ikram El Zaoui, Serge Leyvraz, Carlo Rivolta, Michael Nicolas, Nicola Bedoni, Maya Bucher, Ann Schalenbourg, Nicolo Riggi
Publikováno v:
Investigative ophthalmology & visual science, vol. 60, no. 7, pp. 2764-2772
Investigative Ophthalmology & Visual Science, Vol. 60, No 7 (2019) pp. 2764-2772
Investigative Ophthalmology & Visual Science, Vol. 60, No 7 (2019) pp. 2764-2772
To analyze the activity of mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinases/mechanistic target of rapamycin (PI3K/mTOR) pathways in benign and malignant conjunctival melanocytic proliferations and explore whether specific inhibi
Publikováno v:
Annales de Pathologie. 26:207-210
Resume La leiomyomatose peritoneale disseminee (LPD) est une entite rare. Elle se caracterise par la presence de multiples nodules de cellules musculaires lisses dans la cavite peritoneale, simulant une carcinose peritoneale. L’evolution de cette p
Publikováno v:
Acta Ophthalmologica. 92
Purpose As activating mutations of BRAF and NRAS have been identified in 47% of conjunctival melanoma, we evaluated the activation status of the MAP kinase and PI3K/mTOR pathways in benign and malignant conjunctival melanocytic proliferations. As los
Publikováno v:
Annales de pathologie. 26(3)
Leiomyomatosis peritonealis disseminata (LPD) is a rare disease presenting as multiple peritoneal nodules of smooth muscle cells, mimicking peritoneal carcinomatosis. This disease usually pursues a benign course. We report one case of LPD in a 32-yea